Shopping Cart
- Remove All
Your shopping cart is currently empty
Apoptosisinducer 25 (Compound 4H) demonstrates potent anticancer capabilities by inhibiting the proliferation of BGC-823 cancer cells with an IC50 of 0.37 μM. It induces apoptosis in BGC-823 cells, causes mitochondrial dysfunction, and arrests the cell cycle at the G2/M phase. Additionally, Apoptosisinducer 25 exhibits favorable pharmacokinetic properties in rats.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks |
| Description | Apoptosisinducer 25 (Compound 4H) demonstrates potent anticancer capabilities by inhibiting the proliferation of BGC-823 cancer cells with an IC50 of 0.37 μM. It induces apoptosis in BGC-823 cells, causes mitochondrial dysfunction, and arrests the cell cycle at the G2/M phase. Additionally, Apoptosisinducer 25 exhibits favorable pharmacokinetic properties in rats. |
| Molecular Weight | 683.87 |
| Formula | C42H53NO7 |
| Cas No. | 2763063-15-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.